This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing the results from the OASIS-HAE and OASISplus studies of donidalorsen in patients with hereditary angioedema

Ticker(s): IONS

Who's the expert?

Institution: Allergy Specialists

  • Board certified Internist and Allergist in private practice in Dallas, Texas treating adults and children with allergic diseases and asthma. 
  • Clinical Professor of Internal Medicine at the University of Texas Southwestern Medical School in Dallas and teaches at Parkland Memorial and Presbyterian Hospitals in Dallas. 
  • Follows 140 type 1 and 2 patients with HAE.
  • Member of the U.S. Hereditary Angioedema Association and on the panel responsible for the HAWK, ICON and WAO hereditary angioedema consensus documents.

Interview Goal
This call will feature a discussion on the current standard of care and the potential of donidalorsen, an investigative prophylactic medicine being developed by Ionis Pharma to prevent HAE attacks.

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.